Tuesday Aug 12 | BioSpace
Geron Corporation and Exeter Life Sciences, Inc. Merge stART...
Geron Corporation and Exeter Life Sciences, Inc. Merge stART Licensing, Inc. and ViaGen, Inc.
Geron Initiates Clinical Trial Of GRN163L In Combination With...
Geron Corporation announced the enrollment of the first patient in a clinical trial of its telomerase inhibitor drug, GRN163L, in locally recurrent or metastatic breast cancer.
Geron Corp. reports $13.6M loss in Q2
Geron Corp. lost $13.6 million in the second quarter ended June 30, compared with a loss of $14 million in the same quarter a year earlier.
Geron Says Its Embryonic Cells For Heart Won't Make Immune System React
Geron Corp. said it may be able to inject its experimental stem cells into people to treat heart failure without triggering a life-threatening response by the body's immune system, in research presented today.
Wall Street Media Presents Exclusive Videos from the Needham Biotech Conference
Wall Street Media is presenting exclusive highlight videos from the presentations of Varian Medical Systems Inc., , Geron Corp., , and CuraGen Corp., , at the Needham 7 th Annual Biotechnology & Medical ...
Geron Presentations at the ASCO 2008 Annual Meeting
Geron Corporation today announced two presentations of its anti-cancer drug, GRN163L, given at the American Society of Clinical Oncology annual meeting in Chicago.
Geron Corporation Q1 2008 Earnings Call Transcript
David Greenwood - EVP, CFO Tom Okarma - CEO Analysts Glen Gechlik- Needham & Co.
Q&A: The Man Who Created Embryonic Stem Cells
Ten years ago in a small, closet-like laboratory, James "Jamie" Thomson, an embryologist at the University of Wisconsin, Madison, changed the world by creating the first human embryonic stem cells.
Bush condems disabled to wheel chair, again. Embryonic stem cell trial prohibited
Bush FDA wing-nut god appointee denies spinal cord INJURY REPAIR trial for the second time, even though the company met all of the bush fda requirements, both times::: A legacy that history should rightly call ...
Start Licensing Grants BioArts International Sole License with...
Start Licensing, Inc. today announced that it has granted a sole, worldwide license for the cloning of dogs, cats and endangered species to BioArts International, Ltd.
Stock Market Watch for Thursday, May 15, 2008: PUBM Attains True Milestone
TheSUBWAY.com: Names the following stocks to its Stock Watch List: Public Media Works, Inc.
STEMCELL Technologies, Inc. Licenses Geron Intellectual Property for the Development of Media
VANCOUVER & MENLO PARK, Calif. - STEMCELL Technologies, Inc. and Geron Corporation today announced that Geron has granted a license to STEMCELL Technologies under Geron intellectual property relating to primate ...
Geron shares recover after drop on study delay
“Once we have the letter and have had a discussion with the agency, we will communicate our finding and our thinking to shareholders”
Shares of biotechnology company Geron Corp. regained some ground Thursday, following a prior-day plunge on the Food and Drug Administration's decision to place a clinical hold on a planned stem-cell study. via International Business Times
FDA Places Geron's GRNOPC1 IND on Clinical Hold
“We have not yet received a letter from the FDA explaining the decision to place the submission on hold, so we are unable to comment specifically”
May 14, 2008 - Geron Corporation announced today that the company received verbal notice today from the FDA that the company's Investigational New Drug submission for GRNOPC1, a cell therapy for spinal cord ... via Med Ad News
Anti-Cancer stem cell drug, nontoxic, nasal drops, works in brain
It is huge medical news that you won't read about in the press, and it illustrates the power of Geron's first in man telomerase inhibitor. via Toledo Talk
University Of Edinburgh Human Embryonic Stem Cell Program Awarded UK Grant Funding
“Because of the receptiveness in the UK, we have major collaborations in place at the University of Edinburgh, the University of Birmingham and Oxford.”
Geron Corporation announced two grant awards to the University of Edinburgh from the UK Stem Cell Foundation, with funding from the Medical Research Council and Scottish Enterprise. via MediLexicon
Geron Corporation awarded UK grant funding for human embryonic stem cell research
“The government has made a major investment in creating the Centre and this grant will allow us to progress toward our goal of delivering new treatments for debilitating diseases.”
Geron Corporation announced today two grant awards to the University of Edinburgh from the UK Stem Cell Foundation, with funding from the Medical Research Council and Scottish Enterprise. via Medical News
Geron Announces Conference Call to Discuss Financial Results for the 2008 First Quarter
Thomas B. Okarma, Ph.D., M.D., Geron's chief executive officer, and David L. Greenwood, Geron's chief financial officer, will host a conference call for analysts and investors on Wednesday, April 30 at 8:00 ... via PR-inside.com
Geron Presentations at the AACR 2008 Annual Meeting
“These Geron presentations and the many others on telomerase and cancer continue to highlight the importance of telomerase-targeted therapeutics for the treatment of cancer”
Apr 16, 2008 - Geron Corporation today announced five presentations of its anti-cancer drug, GRN163L, given at this year's American Association for Cancer Research Annual Meeting in San Diego, CA. via Med Ad News
The San Francisco Business Times
Geron gets $1.5M milestone after FDA study says cloned animals safe to eat
Exeter Life Sciences Inc. paid Geron Corp. $1.5 million as a milestone payment. The two companies started a joint venture two years ago around cloned animal research and technology. via The San Francisco Business Times
Read more articles in the Geron News Archives.
For up to the minute news, check out the Geron News Wire.
Want to add Geron News headlines to your web site? Get the widget here.
Comment?
Talk about Geron
Do you have something to say about Geron? 
Geron Poll
Top Stories
Most Popular
News Trends
